A.O. di Padova
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casaluci
EMN36, NCT06237803: European Myeloma Network (EMN) Sample Project

Recruiting
N/A
6000
Europe, RoW
storage of biological samples
Stichting European Myeloma Network, Janssen, LP
Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma, MGUS
12/37
12/37
Mannina
XPORT-MM-031, NCT05028348 / 2021-001691-41: A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Calendar Jul 2024 - Dec 2024: Top-line data from XPORT-MM-031 trial in combination with pomalidomide and dexamethasone for multiple myeloma
Jun 2023 - Dec 2023: Completion of enrolment of trial in combination with pomalidomide and dexamethasone for multiple myeloma
Recruiting
3
222
Europe, US
Selinexor, KPT-330, Elotuzumab, Pomalidomide, Dexamethasone Oral
Stichting European Myeloma Network, Karyopharm Therapeutics Inc
Multiple Myeloma
03/26
03/29
ERASMM, NCT06183489: Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

Recruiting
2
50
Europe
Elranatamab
Stichting European Myeloma Network, Pfizer
Smoldering Multiple Myeloma
07/27
07/31

Download Options